Quest Diagnostics
DGX
#1095
Rank
โ‚ฌ17.52 B
Marketcap
156,74ย โ‚ฌ
Share price
-0.91%
Change (1 day)
6.76%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Market capitalization of Quest Diagnostics (DGX)

Market cap: โ‚ฌ17.52 Billion

As of December 2025 Quest Diagnostics has a market cap of โ‚ฌ17.52 Billion. This makes Quest Diagnostics the world's 1095th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Quest Diagnostics from 1997 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ17.52 B7.06%
2024โ‚ฌ16.37 B16.74%
2023โ‚ฌ14.02 B-15.57%
2022โ‚ฌ16.60 B-11.37%
2021โ‚ฌ18.74 B43.53%
2020โ‚ฌ13.05 B2.98%
2019โ‚ฌ12.67 B29.03%
2018โ‚ฌ9.82 B-12.17%
2017โ‚ฌ11.18 B-7.63%
2016โ‚ฌ12.11 B30.19%
2015โ‚ฌ9.30 B17.18%
2014โ‚ฌ7.93 B42.22%
2013โ‚ฌ5.58 B-19.96%
2012โ‚ฌ6.97 B-1.11%
2011โ‚ฌ7.05 B1.82%
2010โ‚ฌ6.92 B-10.33%
2009โ‚ฌ7.72 B6.35%
2008โ‚ฌ7.26 B3.26%
2007โ‚ฌ7.03 B-9.71%
2006โ‚ฌ7.79 B-9.67%
2005โ‚ฌ8.62 B20.99%
2004โ‚ฌ7.12 B19.4%
2003โ‚ฌ5.97 B11.97%
2002โ‚ฌ5.33 B-31.61%
2001โ‚ฌ7.79 B11.14%
2000โ‚ฌ7.01 B423.27%
1999โ‚ฌ1.34 B197.39%
1998โ‚ฌ0.45 B5.71%
1997โ‚ฌ0.42 B

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Quest Diagnostics was reported to be:

โ‚ฌ17.43 Billion
by Nasdaq info icon info icon
โ‚ฌ17.52 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
LabCorp
LH
โ‚ฌ18.44 B 5.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
โ‚ฌ13.51 M-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
โ‚ฌ1.32 B-92.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
โ‚ฌ31.42 M-99.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚ฌ2.42 B-86.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚ฌ8.75 B-50.05%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands